Loading…
Guardian Pharmacy Services, Inc. is projected to rise to $56.67 by 2027, a +38% move from its current price of $41.20. GRDN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $40.46 | $41.22 | $42.00 | +0.05% |
| Aug 2 | $40.16 | $41.24 | $42.35 | +0.11% |
| Aug 3 | $39.95 | $41.27 | $42.63 | +0.16% |
| Aug 4 | $39.77 | $41.29 | $42.86 | +0.21% |
| Aug 5 | $39.61 | $41.31 | $43.08 | +0.26% |
| Aug 6 | $39.47 | $41.33 | $43.27 | +0.32% |
| Aug 7 | $39.35 | $41.35 | $43.46 | +0.37% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $39.35 | $41.35 | $43.46 | +0.37% |
| Week 2 | $38.69 | $41.50 | $44.52 | +0.74% |
| Week 3 | $38.23 | $41.66 | $45.40 | +1.11% |
| Week 4 | $37.86 | $41.81 | $46.17 | +1.48% |
| Week 5 | $37.56 | $41.97 | $46.89 | +1.86% |
| Week 6 | $37.30 | $42.12 | $47.56 | +2.23% |
| Week 7 | $37.08 | $42.28 | $48.21 | +2.61% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Guardian Pharmacy Services, Inc. is a healthcare company that provides pharmacy services to residents in long-term health care facilities in the United States. Its suite of technology-enabled capabilities supports LTCFs, including individualized clinical, drug dispensing, and administration services, along with tools such as Guardian Compass dashboards, GuardianShield Programs, Order Entry QA Analyzer, and Medication Spend Analyzer.
Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
The company operates in the Healthcare category and serves residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. These offerings are designed to help local pharmacies plan, track, and optimize their operations and spend, aligning clinical needs with procurement and administration processes.
Guardian Pharmacy Services, Inc. (GRDN) currently trades at $41.46 with a market cap of $2.63B and is ranked 1757. The stock’s near-term technical picture shows bullish undertones, supported by an RSI of 60 and moving averages at $40.17 (SMA50) and $34.07 (SMA200).
Its 30-day price range runs from $36.37 to $47.27, with a near-term support level of $38.33 and a resistance at $43.40. Forecasts project a strong upward trajectory across multiple years, with substantial upside implied by rising average prices and positive ROI further out.
A major floor 17.1% below — a decisive break under it would weaken the trend.
The nearest floor, 7.0% below — buyers have tended to step in here.
The nearest ceiling, 5.3% above — a clean break opens room to run.
A major ceiling 11.8% above — clearing it would confirm fresh momentum.
Key GRDN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GRDN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $41.19 | Buy | $41.06 | Buy |
| MA 10 | $40.64 | Buy | $40.84 | Buy |
| MA 20 | $40.62 | Buy | $40.71 | Buy |
| MA 50 | $40.47 | Buy | $40.04 | Buy |
| MA 100 | $38.47 | Buy | $38.28 | Buy |
| MA 200 | $34.34 | Buy | $34.88 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.16 | Neutral |
| Stoch RSI (14) | 68.32 | Neutral |
| CCI (20) | 61.93 | Neutral |
| Williams %R (14) | -27.27 | Info |
| MACD (12,26,9) | 0.08 | Buy |
| ROC (12) | 3.86 | Buy |
| Bollinger %B (20,2) | 0.70 | Neutral |
| Stochastic %K (14) | 72.73 | Neutral |
| TRIX (15) | 0.01 | Buy |
| Awesome (5,34) | 0.17 | Buy |
| Ultimate (7,14,28) | 51.69 | Neutral |
| Momentum (10) | 0.83 | Buy |
| Aroon Osc (25) | 8.00 | Buy |
| Hull MA (9) | 41.72 | Sell |
| ADX (14) | 9.93 | Neutral |
| ATR (14) | 0.71 | Info |
The 30-day technical picture suggests a bullish tilt. RSI14 is 60, indicating room to move higher without being overbought. The SMA50 sits at $40.17 and the SMA200 at $34.07, framing a positive trend within the current price vicinity.
Trading activity is contained within a 30-day range of $36.37 to $47.27, providing near-term support near $38.33 and resistance near $43.40. The setup points to upside potential if the price breaks above $43.40, with risk managed around the $38.33 support level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $27.03 | $41.20 | $56.63 | 0% | Neutral | |
| $46.46 | $56.67 | $72.22 | +38% | Bullish | |
| $55.98 | $69.57 | $91.10 | +69% | Bullish | |
| $61.23 | $77.28 | $103.37 | +88% | Bullish | |
| $68.10 | $87.13 | $118.66 | +111% | Bullish | |
| $80.22 | $103.89 | $143.74 | +152% | Bullish | |
| $100.37 | $131.46 | $184.49 | +219% | Bullish | |
| $117.76 | $155.86 | $221.58 | +278% | Bullish | |
| $124.80 | $166.83 | $240.01 | +305% | Bullish | |
| $134.99 | $182.16 | $264.99 | +342% | Bullish | |
| $230.89 | $324.99 | $495.52 | +689% | Bullish | |
| $450.86 | $680.67 | $1,112.61 | +15.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $27.03 | $41.20 | $48.03 | +0.00% |
| August 2026 | $36.88 | $43.00 | $51.10 | +4.37% |
| September 2026 | $36.86 | $43.23 | $51.85 | +0.53% |
| October 2026 | $37.16 | $43.77 | $52.89 | +1.27% |
| November 2026 | $38.45 | $45.46 | $55.27 | +3.86% |
| December 2026 | $39.04 | $46.33 | $56.63 | +1.90% |
Click any year to see its month-by-month GRDN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Guardian Pharmacy Services, Inc.'s 2026 outlook centres on $41.20, within a $27.03 to $56.63 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, GRDN could reach as high as $72.22, with a base case around $56.67 and support toward $46.46 — roughly +38% from $41.20. Buyers look set to stay in control over this stretch.
Expect GRDN to range from $55.98 to $91.10 through 2028. The $69.57 average target implies a +69% move from current prices. That is up +23% on the projected 2027 average. Momentum favours further upside here.
The GRDN price prediction for 2029 points to an average of $77.28 (low $61.23, high $103.37) — a potential gain of +88% on today's $41.20. Buyers look set to stay in control over this stretch.
In 2030, GRDN is projected to trade between $68.10 and $118.66, averaging $87.13 — a potential gain of +111% from today's $41.20. That is up +13% on the projected 2029 average. Momentum favours further upside here.
Guardian Pharmacy Services, Inc.'s 2031 outlook centres on $103.89, within a $80.22 to $143.74 range. That is up +19% on the projected 2030 average. That marks a +152% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, GRDN could reach as high as $184.49, with a base case around $131.46 and support toward $100.37 — roughly +219% from $41.20. Momentum favours further upside here.
Expect GRDN to range from $117.76 to $221.58 through 2033. The $155.86 average target implies a +278% move from current prices. That is up +19% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The GRDN price prediction for 2034 points to an average of $166.83 (low $124.80, high $240.01) — a potential gain of +305% on today's $41.20. Momentum favours further upside here.
In 2035, GRDN is projected to trade between $134.99 and $264.99, averaging $182.16 — a potential gain of +342% from today's $41.20. That is up +9% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Guardian Pharmacy Services, Inc.'s 2040 outlook centres on $324.99, within a $230.89 to $495.52 range. That is up +78% on the projected 2035 average. That marks a +689% change versus current levels. Momentum favours further upside here.
By 2050, GRDN could reach as high as $1,112.61, with a base case around $680.67 and support toward $450.86 — roughly +15.5x from $41.20. Buyers look set to stay in control over this stretch.
Investing $1,000 in GRDN today (≈ 24.271845 GRDN) could be worth
$16,521.24
+$15,521.24 (+1552%) by 2050 · US Dollar
Based on the average projected GRDN price of $680.67 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GRDNwould be worth at today's price.
$1,000 invested in GRDN on Jul 30, 2025 (≈ 48.828126 GRDN) would be worth
$2,011.72
+$1,011.72 (+101.2%) today · 2.01× · US Dollar
Based on a GRDN entry price of $20.48 vs. today's $41.2.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $39.44 | $1,044.62 | +4.5% |
| 1 month ago | $41.87 | $984 | -1.6% |
| 3 months ago | $37.37 | $1,102.49 | +10.2% |
| 6 months ago | $30.2 | $1,364.24 | +36.4% |
| 1 year ago | $20.48 | $2,011.72 | +101.2% |
| All time (1.8y) ago | $16 | $2,575 | +157.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GRDN forecast.
Our base-case forecast reaches $82.00 around 2030.
Implied market cap at $82.00: $4.08B
The multi-year forecasts show a pronounced uptrend starting in 2026 and extending through 2050. The 2026 forecast places the avg at $41.46 with a min of $27.03 and a max of $57.43, yielding a neutral sentiment and ROI of 0.
In 2030, the avg rises to $91.73 with a min of $71.25 and a max of $125.97, and a projected ROI of 121.2% with a bullish sentiment. The trajectory continues higher in 2040, where the avg is $362.43 (min $254.28; max $559.92) and ROI is 774.2%. By 2050, the avg is $774.95 (min $504.41; max $1,287.06) with a ROI of 1769.2% and bullish sentiment.
These figures illustrate a strong, long-run upside, though they are estimates and not guarantees.
Additional year-by-year anchors show persistent growth in the late 2020s and early 2030s, underscoring a sustained bullish outlook while acknowledging that actual results may differ from the projections.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $91.73 with a min of $71.25 and a max of $125.97, and a projected ROI of 121.2% with a bullish sentiment.
Forecasts indicate a bullish trajectory in multiple years, with positive ROI in 2027 (ROI 39.7%), 2028 (ROI 73.8%), 2034 (ROI 337%), and 2050 (ROI 1769.2%), among others.
Yes. The 2030 max forecast is $125.97, which exceeds $100 (the 2030 avg is $91.73 and the min is $71.25).
Current price: $41.46. Market cap: $2.63B.
The 30-day range is $36.37 to $47.27, with near-term support at $38.33 and resistance at $43.40.
Guardian Pharmacy Services, Inc. Community Discussion
0Share your Guardian Pharmacy Services, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.